lenalidomide has been researched along with Hemangioendothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreani, M; Cardot-Leccia, N; Di Filippo, Y; Lacour, JP; Long-Mira, E; Montaudié, H; Passeron, T; Richez, V | 1 |
| Boyapati, A; Khan, S; Mar, A; Sheridan, A | 1 |
2 other study(ies) available for lenalidomide and Hemangioendothelioma
| Article | Year |
|---|---|
Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide.
Topics: Hemangioendothelioma; Humans; Lenalidomide; Paraproteinemias; Skin Neoplasms | 2021 |
Reactive angioendotheliomatosis associated with cyroglobulinemia in a marathon runner.
Topics: Aged; Angiogenesis Inhibitors; Cryoglobulinemia; Hemangioendothelioma; Humans; Lenalidomide; Male; Running; Skin Neoplasms; Thalidomide | 2013 |